tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Shawn Egan, 2 are a BUY (50%), 2 are a HOLD (50%).
Analyst Shawn Egan, currently employed carries an average stock price target met ratio of 75% that have a potential upside of 19.73% achieved within 69 days.
Shawn Egan’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals at 07-Feb-2024.
Analyst best performing recommendations are on ARWR (ARROWHEAD PHARMACEUTICALS).
The best stock recommendation documented was for ARWR (ARROWHEAD PHARMACEUTICALS) at 11/19/2020. The price target of $90 was fulfilled within 78 days with a profit of $21.08 (30.59%) receiving and performance score of 3.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$80
$60.5 (310.26%)
$80
1 days ago
(20-Dec-2024)
0/21 (0%)
$60.5 (310.26%)
Buy
$60
$40.5 (207.69%)
$60
9 days ago
(12-Dec-2024)
4/18 (22.22%)
$37.86 (171.00%)
193
Buy
$45
$25.5 (130.77%)
$62
24 days ago
(27-Nov-2024)
22/36 (61.11%)
$21.03 (87.73%)
154
Buy
$42
$22.5 (115.38%)
$50
2 months 25 days ago
(26-Sep-2024)
2/9 (22.22%)
$22.38 (114.07%)
100
Buy
$55
$35.5 (182.05%)
$55
4 months 9 days ago
(12-Aug-2024)
8/15 (53.33%)
$32.06 (139.76%)
135
What Year was the first public recommendation made by Shawn Egan?
